Indication

Acute lymphoid leukemia

Acute lymphoid leukemia, more commonly termed acute lymphoblastic or lymphocytic leukemia (ALL), is a fast-growing hematologic malignancy characterized by the clonal proliferation and accumulation of immature lymphoid progenitor cells (lymphoblasts) of B- or T-cell lineage. Read more about Acute lymphoid leukemia

509 drugs 215 manufacturers

Advertisement

Drugs that treat it

Common Acute lymphoid leukemia therapies.

Showing 343–351 of 509 drugs

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
CARDINAL HEALTH

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
GSMS, INC.

PREDNISONE

GLUCOCORTICOSTEROIDS·PULMONARY TUBERCULOSIS·+67
GSMS, INC.

DEXAMETHASONE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61
APOTEX CORP
Filter & compare in the drug finder →Opens the drug finder with Acute lymphoid leukemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Acute lymphoid leukemia.

Acute lymphoid leukemia, more commonly termed acute lymphoblastic or lymphocytic leukemia (ALL), is a fast-growing hematologic malignancy characterized by the clonal proliferation and accumulation of immature lymphoid progenitor cells (lymphoblasts) of B- or T-cell lineage.

The disease primarily targets the bone marrow and peripheral blood, frequently infiltrating extramedullary tissues such as the lymph nodes, spleen, liver, and central nervous system.

Although it can develop at any age, it is the most common childhood malignancy.

Pathophysiologically, the rapid overgrowth of leukemic blasts displaces normal hematopoietic precursors, leading to bone marrow failure typically manifested by anemia, thrombocytopenia, and neutropenia, which precipitate fatigue, bleeding, and recurrent infections.

Personalize your experience

Follow Acute lymphoid leukemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it